Alligator Bioscience

Alligator Bioscience develops antibody-based immunotherapies for the treatment of cancer by using its protein optimization technology FIND.

Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for immunotherapy of cancer. Alligator discovers and develops drug development candidates up to phase IIa clinical studies. Alligator’s pipeline currently counts three immune-modulating projects, ADC-1013, ADC-1015, and ADC-1016. Alligator uses its proprietary technology platforms: ALLIGATOR-GOLD, a unique fully human antibody library, and FIND (Fragment INduced Diversity), a powerful in vitro based antibody optimization technology, in growing our pipeline.